Michael Morse isn’t the only big leaguer trying to get healthy via platelet-rich plasma treatment this week, as Orioles left-hander Zach Britton also underwent the procedure in an attempt to avoid shoulder surgery.
Dr. James Andrews recommended the new and somewhat controversial treatment for Britton, who’s struggled with shoulder inflammation dating back to August of last season.
Britton is expected to meet again with Dr. Andrews next month, so he’ll definitely begin the season on the disabled list and is no sure thing to rejoin the Orioles’ rotation in the first half, but for now avoiding going under the knife is relatively positive news.
Tim Tebow isn’t letting go of his major league dreams just yet. The former NFL quarterback is slated to appear with the Mets during spring training this year, extending what initially looked like an ill-fated career choice for at least one more season. Per the club’s official announcement on Friday, he’ll join a group of spring training invitees that includes top-30 prospects like Peter Alonso, P.J. Conlon, Patrick Mazeika and David Thompson.
Tebow, 30, hasn’t taken to professional baseball as gracefully as expected. He batted a cumulative .226/.309/.347 with eight home runs and a .656 OPS in 486 plate appearances for Single-A Columbia and High-A St. Lucie in 2017. While that wasn’t enough to compel the Mets to give the aging outfielder a big league tryout, there’s no denying that Tebow brought substantial benefit to their minor league affiliates — in the form of increased attendance figures and ticket sales, that is.
Even after the Mets were booted from the NL East race last September, they resisted the idea of promoting Tebow for a late-season attendance boost of their own. That’s not to say they’re planning on taking the same approach in 2018; Tebow will undoubtedly get his cup of coffee in the majors at some point, but for now, a Grapefruit League tryout is likely as close as he’ll ever get to playing with the team’s big league roster on an everyday basis.